The efficacy of AM6545 treatment in CaMKII-CB1-RS and Ati-CB1-RS mice in reducing body weight and food intake suggests that peripheral CB1 in sympathetic pre- or postganglionic neurons and adipocytes are potential targets in obesity. The gene discussed is CAMK2G; the disease is obesity disorder.